Joel Ojeda-Rivera
NPI 1275706194ActiveIndividual· Internal Medicine, Rheumatology· Arecibo, PR
Internal Medicine, Rheumatology in Arecibo, Puerto Rico, licensed in PR, with an NPI issued in April 2008. Part D covered 5,482 prescriptions written in 2024, 87% of them generic. Glaxosmithkline, LLC. reported $14.11 in payments in 2025, mostly food and beverage.
Overview
| NPI | 1275706194 |
|---|---|
| Status | Active |
| Entity type | Individual |
| Sole proprietor | Yes |
| NPI issued | Apr 11, 2008 |
| Last updated in NPPES | Jul 10, 2014 |
Specialties and licenses
| Taxonomy | Code | License | State |
|---|---|---|---|
| Internal Medicine, Rheumatology Primary | 207RR0500X | 18373 | PR |
| Internal Medicine | 207R00000X | 18373 | PR |
Exclusion screening
| List | Result | Details |
|---|---|---|
| HHS-OIG LEIE · Nov 10, 2026 | No match | Checked by NPI and by name + state |
| North Carolina Medicaid · Nov 11, 2026 | No match | — |
| New York OMIG · Nov 11, 2026 | No match | — |
| Ohio Medicaid · Nov 11, 2026 | No match | — |
| Pennsylvania Medicheck · Nov 11, 2026 | No match | — |
| Washington HCA · Nov 11, 2026 | No match | — |
Official OIG search · How matching works ·Bulk check a roster
Medicare
| Enrollment (PECOS) | Enrolled Practitioner - Internal Medicine (PR) |
|---|
Part D prescriptions in 2024
| Prescriptions (claims) | 5,482 · 6,061 30-day fills |
|---|---|
| Patients | 973 |
| Total drug cost | $2,952,238 |
| Generic share | 87% of claims |
Industry payments (Open Payments)
- 2025$14.11 · 1 payment from 1 company
- 2024$116.15 · 1 payment from 1 company
Top paying companies in 2025
| Company | Amount | Payments |
|---|---|---|
| Glaxosmithkline, LLC. | $14.11 | 1 |
What the 2025 payments were for
- Food and Beverage$14.11 · 1 payment
Receiving payments does not imply wrongdoing. What Open Payments covers ·original records